Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: A pet study

Nora D. Volkow, Gene Jack Wang, Joanna S. Fowler, Robert Hitzemann, Samuel J. Gatley, Stephen S. Dewey, Naomi Pappas

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Objective: Because cocaine enhances dopamine brain activity and dopamine signals are transferred through γ-aminobutyric acid pathways, the authors hypothesized GABA-ergic disruption in cocaine-abusing subjects. This study tests this hypothesis. Method: GABA brain function was assessed indirectly by measuring the brain metabolic responses to lorazepam, a drug that facilitates GABA neurotransmission. Thirteen current cocaine-abusing subjects and 14 comparison subjects were scanned twice with positron emission tomography and [18F]fluorodeoxyglucose; the first scan was obtained after placebo administration and the second after lorazepam administration (30 μg/kg). Results: Despite significantly higher plasma lorazepam concentrations in comparison subjects than in cocaine-abusing subjects, lorazepam-induced decrements in whole brain metabolism were significantly greater in cocaine- abusing (mean=21%, SD=13%) than in comparison (mean=13 %, SD=7%) subjects. These differences were largest in striatum, thalamus, and parietal cortex. Lorazepam-induced sleepiness in cocaine-abusing subjects was intense and was significantly greater than in comparison subjects, and it was correlated with lorazepam-induced changes in thalamic metabolism. Whereas regional metabolic measures during placebo administration were significantly higher in cocaine- abusing subjects than in comparison subjects, the measures during lorazepam administration were equivalent for both groups. Conclusions: The enhanced sensitivity to lorazepam in cocaine-abusing subjects suggests disruption of GABA pathways that may reflect, in part, cocaine withdrawal. The intense sleepiness induced by lorazepam in some of the abusers, despite their significantly lower plasma concentrations, should alert clinicians of the potential toxicity from accentuated responses to sedative hypnotics in active cocaine-abusing subjects.

Original languageEnglish (US)
Pages (from-to)200-206
Number of pages7
JournalAmerican Journal of Psychiatry
Volume155
Issue number2
StatePublished - 1998
Externally publishedYes

Fingerprint

Lorazepam
Pets
Benzodiazepines
Cocaine
gamma-Aminobutyric Acid
Brain
Dopamine
Placebos
Aminobutyrates
Parietal Lobe
Fluorodeoxyglucose F18
Hypnotics and Sedatives
Thalamus
Synaptic Transmission
Positron-Emission Tomography

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Volkow, N. D., Wang, G. J., Fowler, J. S., Hitzemann, R., Gatley, S. J., Dewey, S. S., & Pappas, N. (1998). Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: A pet study. American Journal of Psychiatry, 155(2), 200-206.

Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects : A pet study. / Volkow, Nora D.; Wang, Gene Jack; Fowler, Joanna S.; Hitzemann, Robert; Gatley, Samuel J.; Dewey, Stephen S.; Pappas, Naomi.

In: American Journal of Psychiatry, Vol. 155, No. 2, 1998, p. 200-206.

Research output: Contribution to journalArticle

Volkow, ND, Wang, GJ, Fowler, JS, Hitzemann, R, Gatley, SJ, Dewey, SS & Pappas, N 1998, 'Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: A pet study', American Journal of Psychiatry, vol. 155, no. 2, pp. 200-206.
Volkow, Nora D. ; Wang, Gene Jack ; Fowler, Joanna S. ; Hitzemann, Robert ; Gatley, Samuel J. ; Dewey, Stephen S. ; Pappas, Naomi. / Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects : A pet study. In: American Journal of Psychiatry. 1998 ; Vol. 155, No. 2. pp. 200-206.
@article{fd584871b5e2453bbb4c71af4ffc3295,
title = "Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: A pet study",
abstract = "Objective: Because cocaine enhances dopamine brain activity and dopamine signals are transferred through γ-aminobutyric acid pathways, the authors hypothesized GABA-ergic disruption in cocaine-abusing subjects. This study tests this hypothesis. Method: GABA brain function was assessed indirectly by measuring the brain metabolic responses to lorazepam, a drug that facilitates GABA neurotransmission. Thirteen current cocaine-abusing subjects and 14 comparison subjects were scanned twice with positron emission tomography and [18F]fluorodeoxyglucose; the first scan was obtained after placebo administration and the second after lorazepam administration (30 μg/kg). Results: Despite significantly higher plasma lorazepam concentrations in comparison subjects than in cocaine-abusing subjects, lorazepam-induced decrements in whole brain metabolism were significantly greater in cocaine- abusing (mean=21{\%}, SD=13{\%}) than in comparison (mean=13 {\%}, SD=7{\%}) subjects. These differences were largest in striatum, thalamus, and parietal cortex. Lorazepam-induced sleepiness in cocaine-abusing subjects was intense and was significantly greater than in comparison subjects, and it was correlated with lorazepam-induced changes in thalamic metabolism. Whereas regional metabolic measures during placebo administration were significantly higher in cocaine- abusing subjects than in comparison subjects, the measures during lorazepam administration were equivalent for both groups. Conclusions: The enhanced sensitivity to lorazepam in cocaine-abusing subjects suggests disruption of GABA pathways that may reflect, in part, cocaine withdrawal. The intense sleepiness induced by lorazepam in some of the abusers, despite their significantly lower plasma concentrations, should alert clinicians of the potential toxicity from accentuated responses to sedative hypnotics in active cocaine-abusing subjects.",
author = "Volkow, {Nora D.} and Wang, {Gene Jack} and Fowler, {Joanna S.} and Robert Hitzemann and Gatley, {Samuel J.} and Dewey, {Stephen S.} and Naomi Pappas",
year = "1998",
language = "English (US)",
volume = "155",
pages = "200--206",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "2",

}

TY - JOUR

T1 - Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects

T2 - A pet study

AU - Volkow, Nora D.

AU - Wang, Gene Jack

AU - Fowler, Joanna S.

AU - Hitzemann, Robert

AU - Gatley, Samuel J.

AU - Dewey, Stephen S.

AU - Pappas, Naomi

PY - 1998

Y1 - 1998

N2 - Objective: Because cocaine enhances dopamine brain activity and dopamine signals are transferred through γ-aminobutyric acid pathways, the authors hypothesized GABA-ergic disruption in cocaine-abusing subjects. This study tests this hypothesis. Method: GABA brain function was assessed indirectly by measuring the brain metabolic responses to lorazepam, a drug that facilitates GABA neurotransmission. Thirteen current cocaine-abusing subjects and 14 comparison subjects were scanned twice with positron emission tomography and [18F]fluorodeoxyglucose; the first scan was obtained after placebo administration and the second after lorazepam administration (30 μg/kg). Results: Despite significantly higher plasma lorazepam concentrations in comparison subjects than in cocaine-abusing subjects, lorazepam-induced decrements in whole brain metabolism were significantly greater in cocaine- abusing (mean=21%, SD=13%) than in comparison (mean=13 %, SD=7%) subjects. These differences were largest in striatum, thalamus, and parietal cortex. Lorazepam-induced sleepiness in cocaine-abusing subjects was intense and was significantly greater than in comparison subjects, and it was correlated with lorazepam-induced changes in thalamic metabolism. Whereas regional metabolic measures during placebo administration were significantly higher in cocaine- abusing subjects than in comparison subjects, the measures during lorazepam administration were equivalent for both groups. Conclusions: The enhanced sensitivity to lorazepam in cocaine-abusing subjects suggests disruption of GABA pathways that may reflect, in part, cocaine withdrawal. The intense sleepiness induced by lorazepam in some of the abusers, despite their significantly lower plasma concentrations, should alert clinicians of the potential toxicity from accentuated responses to sedative hypnotics in active cocaine-abusing subjects.

AB - Objective: Because cocaine enhances dopamine brain activity and dopamine signals are transferred through γ-aminobutyric acid pathways, the authors hypothesized GABA-ergic disruption in cocaine-abusing subjects. This study tests this hypothesis. Method: GABA brain function was assessed indirectly by measuring the brain metabolic responses to lorazepam, a drug that facilitates GABA neurotransmission. Thirteen current cocaine-abusing subjects and 14 comparison subjects were scanned twice with positron emission tomography and [18F]fluorodeoxyglucose; the first scan was obtained after placebo administration and the second after lorazepam administration (30 μg/kg). Results: Despite significantly higher plasma lorazepam concentrations in comparison subjects than in cocaine-abusing subjects, lorazepam-induced decrements in whole brain metabolism were significantly greater in cocaine- abusing (mean=21%, SD=13%) than in comparison (mean=13 %, SD=7%) subjects. These differences were largest in striatum, thalamus, and parietal cortex. Lorazepam-induced sleepiness in cocaine-abusing subjects was intense and was significantly greater than in comparison subjects, and it was correlated with lorazepam-induced changes in thalamic metabolism. Whereas regional metabolic measures during placebo administration were significantly higher in cocaine- abusing subjects than in comparison subjects, the measures during lorazepam administration were equivalent for both groups. Conclusions: The enhanced sensitivity to lorazepam in cocaine-abusing subjects suggests disruption of GABA pathways that may reflect, in part, cocaine withdrawal. The intense sleepiness induced by lorazepam in some of the abusers, despite their significantly lower plasma concentrations, should alert clinicians of the potential toxicity from accentuated responses to sedative hypnotics in active cocaine-abusing subjects.

UR - http://www.scopus.com/inward/record.url?scp=0031882806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031882806&partnerID=8YFLogxK

M3 - Article

C2 - 9464198

AN - SCOPUS:0031882806

VL - 155

SP - 200

EP - 206

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 2

ER -